Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

APHL-CDC Continue Partnership to Strengthen Public Health Labs Internationally

by Global Biodefense Staff
March 12, 2017
NIAID Researcher Conducts Infectious Disease Research Under the Hood

NIAID researcher conducts laboratory studies under the biosafety hood. Image: NIH/NIAID

The Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC) are continuing a jointly sponsored cooperative agreement program to help strengthen public health laboratories across the globe.

A national nonprofit, APHL represents state and local governmental public health laboratories monitoring and detecting health threats in the United States.

The first cooperative agreement between the US Centers for Disease Control (CDC) and APHL began in 1989. The relationship has broadened ever since and now encompasses the range of public health. APHL leverages its long history of laboratory safety training to help build local capacity in biosafety and biosecurity with international partners.

Funding for “CDC-RFA-GH16-1720 – APHL-CDC Partnership to Strengthen Public Health Laboratories Internationally” is being made available for grantees previously awarded under the program.

This continuation funding is provided from the following sources:

  • Antibiotic Resistance
  • Global Disease Detection
  • Global Health Security
  • Immunization Program – Pandemic Influenza (No-Year) (PHSSEF)
  • Influenza Planning and Response
  • International Ebola
  • International Response and Preparedness-Ebola-Reimbursable Authority
  • National Health Safety Network
  • President’s Emergency Plan for AIDS Relief (GHP)

CDC requires grantees to submit their Annual Performance Reports (APR) by April 14, 2017 which serves as the non-competing continuation application, through www.grants.gov Funding Opportunity Number: CDC-RFA-GH16-172002CONT17.

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC